Physician profile
Aaron K Styer
NPI 1063402360
$13,803.93
in general payments reported to CMS, 2019-2025
6 companies · $31.77 in 2025
The $31.77 reported for 2025 was less than what a typical Reproductive Endocrinology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,526 · 2020: $5,422 · 2021: $1,510 · 2022: $91.50 · 2023: $2,180 · 2024: $42.15 · 2025: $31.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,035 · Food and Beverage: $219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,034.93 |
| Food and Beverage | $219.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $9,634.93 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $2,052.62 | 2023-2025 | Menopur |
| Medtronic, INC. | $1,747.17 | 2021-2023 | Truclear |
| Emd Serono, INC. | $195.76 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $91.69 | 2019-2020 | |
| Minerva Surgical, INC | $81.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Styer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.